Concepedia

Publication | Open Access

761P Impact of the combination of durvalumab (MEDI4736) plus olaparib (AZD2281) administered prior to surgery in the molecular profile of resectable urothelial bladder cancer. NEODURVARIB trial

DOIFull Paper Access

17

Citations

0

References

2020

Year

Juan Francisco Rodríguez-Moreno, Guillermo de Velasco, Carlos Álvarez-Fernández, Ricardo Collado, Ricardo Fernández, S. Vázquez Estévez, Juan Antonio Virizuela Echaburu, P. Gajate Borau, Albert Font, Núria Laínez,
Annals of Oncology

No additional data available for this publication yet. Check back later!